Kolexia
Jorgensen Christian
Rhumatologie
Hôpital Lapeyronie
Montpellier, France
384 Activités
20 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Arthrite Arthrose Polyarthrite rhumatoïde Arthrite expérimentale Inflammation Sclérodermie systémique Sclérose Rhumatismes Gonarthrose

Industries

Fresenius Kabi
3 collaboration(s)
Dernière en 2022
BMS
2 collaboration(s)
Dernière en 2020
UCB
2 collaboration(s)
Dernière en 2022
Novartis
2 collaboration(s)
Dernière en 2020

Dernières activités

PLOD2, a key factor for MRL MSC metabolism and chondroprotective properties.
Stem cell research & therapy   07 mars 2024
NeutroARTherap: Study of the Functional Status Neutrophils in Rheumatoid Arthritis Patients to Identify New Biomarkers of Response to Anti-TNFalpha Therapy
Essai Clinique (CHU Montpellier)   16 janvier 2024
What is the rational for mesenchymal stromal cells based therapies in the management of hemophilic arthropathies?
Osteoarthritis and cartilage   29 décembre 2023
Chronological interplay, clinical features, and treatments among patients with cancer and primary Sjögren's syndrome.
Cancer immunology, immunotherapy : CII   08 novembre 2023
Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method.
Rheumatology (Oxford, England)   11 octobre 2023
Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells.
Nature reviews. Rheumatology   04 septembre 2023
SATIE-PR: An Open Prospective Randomized Controlled Study Comparing the Use of Remote Monitoring by Smartphone in the Care Management of Patients With Rheumatoid Arthritis Versus a Standard Outpatient Follow-up by Physical Consultation
Essai Clinique (CHU Montpellier)   01 septembre 2023
Complex deformation of cartilage micropellets following mechanical stimulation promotes chondrocyte gene expression.
Stem cell research & therapy   30 août 2023
Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing.
Physiological reviews   17 août 2023
ADIPOA-2: A Phase IIb, Prospective, Multicentre, Double-blind, Triple-arm, Randomized Versus Placebo Trial, to Assess the Efficacy of a Single Injection of Either 2 or 10 x 106 Autologous Adipose Derived Mesenchymal Stromal Cells (ASC) in the Treatment of Mild to Moderate Osteoarthritis (OA) of the Knee, Active and Unresponsive to Conservative Therapy for at Least 12 Months
Essai Clinique (CHU Montpellier)   11 août 2023